EUVIMEDEUVIMED entdecken
Crossref

Multiparametric assessment of tumor pathological regression grade of peritoneal metastases from non-mucinous colorectal cancer during neoadjuvant chemotherapy using dual-energy CT

Rémi Grange, Nazim Benzerdjeb, Salim Si-Mohamed, Marie Gavrel, Alexandre Galan, Laurent Villeneuve, Olivier Glehen, Vahan Kepenekian, Pascal Rousset

Diagnostic and Interventional Imaging · 2026

DOI: 10.1016/j.diii.2025.10.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostic and Interventional Imaging, 2026. Verfasst von Rémi Grange und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University Hospital of Saint-Etienne, 42270 Saint-Priest-en-Jarez, EA 3738, Lyon 1 University, 69495 Pierre Bénite, France. …. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Colorectal Neoplasms, Tomography, X-Ray Computed. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The purpose of this prospective study was to evaluate the diagnostic performance of dual-energy computed tomography (DECT) using a dual-layer detector scanner in assessing the pathological response of peritoneal metastases (PMs) from non-mucinous colorectal cancer to neoadjuvant chemotherapy (NAC). MATERIALS AND METHODS: Consecutive patients with PMs from non-mucinous colorectal cancer who underwent preoperative DECT using a dual-layer detector scanner before cytoreductive surgery were prospectively included. Virtual monoenergetic images at 40 keV (VMI40kev), VMIs at 100 keV (VMI100kev), VMI slope (VMIslope), iodine concentration (IC), normalized iodine concentration with aorta (nICaorta) and liver (nICliver), effective Z atomic number (Zeff), and extracellular volume fraction (ECVf) were evaluated on PMs by two radiologists. Pathological response of PM was classified using the peritoneal regression grading score (PRGS), and classified as either good (complete response or major histological regression - PRGS ½) or poor (minor or no histological response - PRGS ¾) responses. DECT variables of PMs with good responses were compared to those of PMs with poor responses using independent-sample t-tests. Receiver operating characteristic curves were built to estimate the capabilities of the different DECT variables in differentiating between PMs with good responses (PRGS ½) and those with poor responses (PRGS ¾). Intra-class correlation coefficients analyses were performed to estimate interobserver variability in DECT variable measurements. RESULTS: Forty-four patients (22 men median age, 62 years; age range: 35-78 years) with 77 PM were included from September 1st 2023 to July 1st 2025. Thirty-nine out of 77 PMs (51 %) exhibited good response (PRGS ½) and 38 PMs (49 %) exhibited poor response (PRGS ¾). VMI40kev, VMIslope, IC, nICaorta, nICliver, ECVf were significantly greater in PRGS ¾ PMs by comparison with PRGS ½ (P 0.8 for most DECT variables. CONCLUSION: DECT using a dual-layer detector scanner provides promising biomarkers for predicting pathological response in non-mucinous PM after chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsColorectal NeoplasmsTomography, X-Ray ComputedHumansMaleFemaleMiddle AgedNeoadjuvant TherapyProspective StudiesAgedAdultRadiography, Dual-Energy Scanned ProjectionNeoplasm Grading

Stichwörter der Autor:innen

Colorectal cancerDual-energy CTDual-layer computed tomographyNeoadjuvant chemotherapyPeritoneal metastases

Autor:innen und Institutionen

  • Department of Radiology, University Hospital of Saint-Etienne, 42270 Saint-Priest-en-Jarez, EA 3738, Lyon 1 University, 69495 Pierre Bénite, France. Electronic address: remi.grange@chu-st-etienne.fr.
  • Department of Pathology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, EA 3738, Lyon 1 University, 69495 Pierre Bénite, France.
  • Department of Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, 69500 Bron, University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, 69622 Villeurbanne, France, France.
  • Department of Radiology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, EA 3738, Lyon 1 University, 69495 Pierre Bénite, France.
  • Department of Clinical Research, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pôle Information Médicale Evaluation Recherche, EA 3738, Lyon 1 University, 69495 Pierre Bénite, France.
  • Department of General Surgery & Surgical Oncology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, EA 3738, Lyon 1 University, 69495 Pierre Bénite, France.

Zitieren

APA

Grange, R., Benzerdjeb, N., Si-Mohamed, S., Gavrel, M., Galan, A., Villeneuve, L., Glehen, O., Kepenekian, V., & Rousset, P. (2026). Multiparametric assessment of tumor pathological regression grade of peritoneal metastases from non-mucinous colorectal cancer during neoadjuvant chemotherapy using dual-energy CT. Diagnostic and Interventional Imaging. https://doi.org/10.1016/j.diii.2025.10.007

Vancouver

Grange R, Benzerdjeb N, Si-Mohamed S, Gavrel M, Galan A, Villeneuve L, et al. Multiparametric assessment of tumor pathological regression grade of peritoneal metastases from non-mucinous colorectal cancer during neoadjuvant chemotherapy using dual-energy CT. Diagnostic and Interventional Imaging. 2026. doi:10.1016/j.diii.2025.10.007

BibTeX
@article{Grange2026,
  author = {Grange, Rémi and Benzerdjeb, Nazim and Si-Mohamed, Salim and Gavrel, Marie and Galan, Alexandre and Villeneuve, Laurent and Glehen, Olivier and Kepenekian, Vahan and Rousset, Pascal},
  title = {Multiparametric assessment of tumor pathological regression grade of peritoneal metastases from non-mucinous colorectal cancer during neoadjuvant chemotherapy using dual-energy CT},
  journal = {Diagnostic and Interventional Imaging},
  year = {2026},
  doi = {10.1016/j.diii.2025.10.007}
}
Kostenlos starten →